Market Capitalization | 778.3K |
Book Value | - $2.78 |
Earnings Per Share (EPS) | -0.67 |
PEG Ratio | 0.0 |
Wall Street Target Price | 5.0 |
Profit Margin | 0.0% |
Operating Margin TTM | -77.4% |
Return On Assets TTM | -78.1% |
Return On Equity TTM | -148.5% |
Revenue TTM | 1.5M |
Revenue Per Share TTM | 0.05 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | -17.4M |
EBITDA | -23.8M |
Diluted Eps TTM | -0.67 |
Quarterly Earnings Growth YOY | -0.93 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|
’s price-to-earnings ratio stands at None
Read MoreA Spac I Acquisition Corp
$0.07
+0.0%
Gamida Cell Ltd
$0.07
+0.0%
Palladyne Ai Corp
$0.07
+0.0%
Keyarch Acquisition Corp
$0.07
+0.0%
Acorda Therapeutics, Inc.
$0.07
+0.0%
Connexa Sports Technologies Inc
$0.07
+0.0%
Semantix Inc
$0.07
+0.0%
Arrowroot Acquisition Corp-a
$0.07
+0.0%
Anfield Capital Diversified Alternatives Etf
$0.07
+0.0%